NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel net income
Net income is the profit left for shareholders after every expense, interest and tax.
Nexgel's net income for the twelve months ending Jun 30, 2026 was -$6.19M. For fiscal 2025 it was -$3.00M. The highest annual figure on record is -$1.89M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.00M | – |
| FY2024 | Dec 31, 2024 | -$3.28M | – |
| FY2023 | Dec 31, 2023 | -$3.16M | – |
| FY2022 | Dec 31, 2022 | -$4.75M | – |
| FY2021 | Dec 31, 2021 | -$4.31M | – |
| FY2020 | Dec 31, 2020 | -$2.26M | – |
| FY2019 | Dec 31, 2019 | -$1.92M | – |
| FY2018 | Dec 31, 2018 | -$1.89M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$927.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$970.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$653.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$665.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$712.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$850.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$693.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$885.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$853.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$550.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$695.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$814.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$648.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.84M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$825.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$704.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$681.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$545.00K | -836.5% |
| Q2 FY2020 | Jun 30, 2020 | -$530.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$507.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$312.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $74.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$612.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$659.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$754.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$288.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$369.00K | – |